Inactive Instrument

Isodiol International Inc. Share Price Canadian Securities Exchange

Equities

ISOL

CA46500L2003

Pharmaceuticals

Financials

Sales 2018 19.14M 26.15M 1.53B Sales 2019 22.25M 30.41M 1.78B Capitalization 49.96M 68.27M 4B
Net income 2018 -36M -49.2M -2.88B Net income 2019 -126M -172M -10.09B EV / Sales 2018 12.6 x
Net cash position 2018 15.55M 21.25M 1.25B Net Debt 2019 5.22M 7.14M 418M EV / Sales 2019 2.48 x
P/E ratio 2018
-4.94 x
P/E ratio 2019
-0.37 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 23/05/17
Director/Board Member - 29/08/18
Corporate Officer/Principal - 13/02/19
Members of the board TitleAgeSince
Chief Executive Officer - 23/05/17
Director/Board Member - 29/08/18
Director/Board Member - 20/11/18
More insiders
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nano-technology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
More about the company